• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患有血色素沉着症的HFE缺陷小鼠中,由二价金属转运蛋白决定的肠道铁吸收增强。

Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis.

作者信息

Griffiths W J, Sly W S, Cox T M

机构信息

University of Cambridge Department of Medicine, Addenbrooke's Hospital, Cambridge, England.

出版信息

Gastroenterology. 2001 May;120(6):1420-9. doi: 10.1053/gast.2001.24050.

DOI:10.1053/gast.2001.24050
PMID:11313312
Abstract

BACKGROUND & AIMS: Overexpression of duodenal divalent metal transporter (DMT1) messenger RNA occurs in hemochromatosis and HFE-knockout mice, suggesting that DMT1 mediates enhanced absorption of iron; however, increased expression of functional DMT1 protein has yet to be substantiated. We examined the role of DMT1 and the mucosal iron uptake defect in HFE-knockout mice.

METHODS

Unidirectional iron uptake of 59Fe by small intestinal mucosa in vitro was compared between matched pairs of HFE-knockout and wild-type mice. DMT1-specific antibodies were used to block iron transport and to quantify duodenal protein expression.

RESULTS

Ferrous iron uptake at 3.5-450 micromol/L was greatly enhanced in HFE-knockouts compared with wild-type, the apparent V(max) for Fe2+ transport being doubled (P < 0.01). Supplied as Fe3+, uptake was only enhanced in HFE-knockouts at < or =18 micromol/L, when the iron was almost completely converted to Fe2+ by mucosal ferrireductases. DMT1 antibody reduced the apparent Vmax for mucosal Fe2+ transport in HFE-knockouts to below wild-type control values (P < 0.02); immunoreactive mucosal DMT1 protein was increased nearly 2-fold in HFE-knockouts (P < 0.01).

CONCLUSIONS

Disruption of the HFE gene up-regulates functional DMT1 transporters and enhances uptake of ferrous iron by this mechanism; DMT1 also mediates increased uptake after reduction of ferric iron presented at physiological concentrations.

摘要

背景与目的

十二指肠二价金属转运体(DMT1)信使核糖核酸在血色素沉着症和HFE基因敲除小鼠中过度表达,提示DMT1介导铁吸收增强;然而,功能性DMT1蛋白表达增加尚未得到证实。我们研究了DMT1的作用以及HFE基因敲除小鼠的黏膜铁摄取缺陷。

方法

比较了配对的HFE基因敲除小鼠和野生型小鼠小肠黏膜对59Fe的单向铁摄取。使用DMT1特异性抗体阻断铁转运并定量十二指肠蛋白表达。

结果

与野生型相比,HFE基因敲除小鼠在3.5 - 450微摩尔/升时亚铁摄取显著增强,Fe2+转运的表观V(max)增加了一倍(P < 0.01)。以Fe3+形式提供时,仅在铁几乎完全被黏膜铁还原酶转化为Fe2+的情况下,HFE基因敲除小鼠在≤18微摩尔/升时摄取增强。DMT1抗体将HFE基因敲除小鼠黏膜Fe2+转运的表观Vmax降低至野生型对照值以下(P < 0.02);HFE基因敲除小鼠中免疫反应性黏膜DMT1蛋白增加了近2倍(P < 0.01)。

结论

HFE基因的破坏上调了功能性DMT1转运体,并通过该机制增强亚铁摄取;DMT1还介导生理浓度下三价铁还原后摄取的增加。

相似文献

1
Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis.在患有血色素沉着症的HFE缺陷小鼠中,由二价金属转运蛋白决定的肠道铁吸收增强。
Gastroenterology. 2001 May;120(6):1420-9. doi: 10.1053/gast.2001.24050.
2
Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains.血色素沉着症基因的失活对不同小鼠品系十二指肠中铁相关信使核糖核酸的表达有不同的调节作用。
Gastroenterology. 2002 Mar;122(3):745-51. doi: 10.1053/gast.2002.31877.
3
Mechanisms and regulation of intestinal iron absorption.肠道铁吸收的机制与调节
Blood Cells Mol Dis. 2002 Nov-Dec;29(3):384-99. doi: 10.1006/bcmd.2002.0578.
4
Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.成年Hfe基因缺陷小鼠的铁过载与十二指肠铁转运蛋白DMT1和Ireg1/铁转运蛋白1的稳态表达变化无关。
J Mol Med (Berl). 2004 Jan;82(1):39-48. doi: 10.1007/s00109-003-0508-x. Epub 2003 Nov 15.
5
Apical distribution of HFE-beta2-microglobulin is associated with inhibition of apical iron uptake in intestinal epithelia cells.HFE-β2-微球蛋白的顶端分布与肠道上皮细胞顶端铁摄取的抑制有关。
Biometals. 2006 Aug;19(4):379-88. doi: 10.1007/s10534-005-6687-x.
6
Genes that modify the hemochromatosis phenotype in mice.在小鼠中改变血色素沉着症表型的基因。
J Clin Invest. 2000 May;105(9):1209-16. doi: 10.1172/JCI9635.
7
Functional and molecular responses of human intestinal Caco-2 cells to iron treatment.人肠道Caco-2细胞对铁处理的功能和分子反应。
Am J Clin Nutr. 2000 Sep;72(3):770-5. doi: 10.1093/ajcn/72.3.770.
8
Nontransferrin-bound iron uptake by hepatocytes is increased in the Hfe knockout mouse model of hereditary hemochromatosis.在遗传性血色素沉着症的Hfe基因敲除小鼠模型中,肝细胞对非转铁蛋白结合铁的摄取增加。
Blood. 2004 Sep 1;104(5):1519-25. doi: 10.1182/blood-2003-11-3872. Epub 2004 May 20.
9
Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.遗传性血色素沉着症患者在接受铁消耗疗法后,二价金属离子转运体1(DMT1)的信使核糖核酸(mRNA)水平升高,但铁调节蛋白1(IREG1)或遗传性血色素沉着症蛋白(HFE)的mRNA水平未升高。
Gut. 2004 Aug;53(8):1174-9. doi: 10.1136/gut.2003.033811.
10
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.遗传性血色素沉着症小鼠模型中铁吸收增加的机制:铁转运蛋白DMT1在十二指肠的表达增加。
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3143-8. doi: 10.1073/pnas.96.6.3143.

引用本文的文献

1
Anticancer Effects of 6-Gingerol through Downregulating Iron Transport and PD-L1 Expression in Non-Small Cell Lung Cancer Cells.6-姜酚通过下调非小细胞肺癌细胞中铁转运和 PD-L1 表达发挥抗癌作用。
Cells. 2023 Nov 15;12(22):2628. doi: 10.3390/cells12222628.
2
Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications.非酒精性肝病中的铁死亡:分子机制与治疗意义
Front Nutr. 2023 Mar 13;10:1090338. doi: 10.3389/fnut.2023.1090338. eCollection 2023.
3
Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in KO Mice.
口服姜衍生脂质纳米颗粒和 Dmt1siRNA 增强了饮食铁限制的效果,并减轻了 KO 小鼠预先存在的铁过载。
Nutrients. 2021 May 15;13(5):1686. doi: 10.3390/nu13051686.
4
Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system.利用 pH 敏感多腔室纳米颗粒口服递药系统实现靶向肠道 DMT1 沉默以减轻铁吸收。
Nanomedicine. 2019 Nov;22:102091. doi: 10.1016/j.nano.2019.102091. Epub 2019 Oct 15.
5
Hereditary Hemochromatosis and Iron Metabolism.遗传性血色素沉着症与铁代谢
EJIFCC. 2001 Jul 22;13(2):31-38. eCollection 2001 Jul.
6
Oral nucleic acid therapy using multicompartmental delivery systems.口服核酸治疗的多腔室递药系统。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Mar;10(2). doi: 10.1002/wnan.1478. Epub 2017 May 24.
7
Mutation in HFE gene decreases manganese accumulation and oxidative stress in the brain after olfactory manganese exposure.HFE基因的突变可减少嗅觉暴露于锰后大脑中的锰积累和氧化应激。
Metallomics. 2016 Jun 1;8(6):618-27. doi: 10.1039/c6mt00080k.
8
HFE gene: Structure, function, mutations, and associated iron abnormalities.HFE基因:结构、功能、突变及相关铁代谢异常
Gene. 2015 Dec 15;574(2):179-92. doi: 10.1016/j.gene.2015.10.009. Epub 2015 Oct 9.
9
Effect of olfactory manganese exposure on anxiety-related behavior in a mouse model of iron overload hemochromatosis.嗅觉暴露于锰对铁过载血色素沉着症小鼠模型中焦虑相关行为的影响。
Environ Toxicol Pharmacol. 2015 Jul;40(1):333-41. doi: 10.1016/j.etap.2015.06.016. Epub 2015 Jun 23.
10
Absorption of manganese and iron in a mouse model of hemochromatosis.血色病小鼠模型中锰和铁的吸收。
PLoS One. 2013 May 21;8(5):e64944. doi: 10.1371/journal.pone.0064944. Print 2013.